PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Flow Pharma, Inc., 3451 Vincent Road, Pleasant Hill, CA 94523, United States.\', \'La Jolla Institute for Allergy and Immunology, 9420 Athena Circle La Jolla, CA 92037, United States.\', \'Endocrinology Division, Department of Medicine, School of Medicine, Columbia University, New York, NY, USA.\', \'University of Texas, Medical Branch, 301 University Blvd, Galveston, TX 77555, United States.\', \'Laboratory of Clinical Immunology and Allergy-LIM60, University of São Paulo School of Medicine, São Paulo, Brazil; Institute for Investigation in Immunology (iii) INCT, São Paulo, Brazil; Heart Institute (Incor), School of Medicine, University of São Paulo, São Paulo, Brazil.\', \'Institute for Investigation in Immunology (iii) INCT, São Paulo, Brazil; Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP/EPM), São Paulo, Brazil.\', \'University of Macau, E12 Avenida da Universidade, Taipa, Macau, China.\', \'Flow Pharma, Inc., 3451 Vincent Road, Pleasant Hill, CA 94523, United States; Massachusetts General Hospital, Department of Anesthesia, Critical Care and Pain Medicine, 55 Fruit St, Boston, MA 02114, United States. Electronic address: reidrubsamen@alum.mit.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(20)30518-110.1016/j.vaccine.2020.04.034
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 32418793
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • An effective CTL peptide vaccine for Ebola Zaire Based on Survivors\' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32418793>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32418793>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all